Trial Profile
Doxorubicin-associated Cardiac Tissue Remodeling Followed by CMR of Myocardial Extracellular Volume and Myocyte Size in Breast Cancer Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Doxorubicin (Primary) ; Gadoterate-meglumine (Primary)
- Indications Breast cancer
- Focus Diagnostic use
- 24 Dec 2016 New trial record